Background: Pharmacists are integral members of the multidisciplinary healthcare team who, with their skills, knowledge, and training, are well positioned to prevent, identify, and manage medication-related issues. Many published articles related to COVID-19 management have highlighted the important role of the pharmacists in assuring the safe, effective, and cost-effective use of medications. During such challenging times of COVID-19 pandemic that resulted in a high demand on medical resources and healthcare providers, pharmacists are well positioned to contribute and add more efforts to the healthcare system to achieve best use of the available resources including medications and providing high quality pharmaceutical care to help the patients and support the healthcare providers. Methods: This is a retrospective chart review included all admitted adult patients with confirmed COVID-19 diagnosis from 1 March 2020 till 30 June 2020. The documented clinical pharmacist interventions were extracted from the EMR and reviewed by multiple clinical pharmacists to identify type, number, frequency, outcome, and physician’s acceptance rate of documented interventions. Results: A total of 484 pharmacist interventions included in the final analysis. Antimicrobial stewardship interventions were the most reported (149, 30.8%) and antibiotics were the most reported class of medication, constituting 31.1% of the total interventions. “Optimized therapy” was the most commonly reported outcome (58.8%). Overall, 50.8% (246) of the interventions were rated as having “moderate” clinical significance using the clinical significance scoring tool. The physicians’ acceptance rate was 94.7%.

Conclusion: Pharmacist interventions are associated with improved communication and medication use in admitted adult patients with COVID-19. Clinical pharmacists can play a crucial role in optimizing medication use in patients with COVID-19 through prevention, identification, and resolving existing or potential drug-related problems.

1. ASHP Coronavirus disease 2019 (COVID-19) resources. Accessed online on 20 February 2021 at: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/Coronavirus
Google Scholar2. Standards of Practice for Clinical Pharmacists American College of Clinical Pharmacy. Lenexa, KS: American College of Clinical Pharmacy; 2020 [cited September 25, 2020]. Available from: https://www.accp.com/about/clinicalpharmacists.aspx
Google Scholar3. Gross, AE, MacDougall, C. Roles of the clinical pharmacist during the COVID-19 pandemic. J Am Coll Clin Pharm. 2020;3:564-566. doi:10.1002/jac5.1231.
Google Scholar | Crossref4. International Pharmaceutical Federation . COVID-19 pandemic: guidelines for pharmacists and the pharmacy workforce, 2020.
Google Scholar5. Stevens, MP, Patel, PK, Nori, P. Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck. Infect Control Hosp Epidemiol. 2020;41:744-745.
Google Scholar | Crossref | Medline6. Cheong, MWL, Brock, T, Karwa, R, Pastakia, SD. COVID-19 and clinical pharmacy worldwide—A wake up call and a call to action. J Am Coll Clin Pharm. 2020;3:860-863.
Google Scholar7. Siddiqui, MA, Abdeldayem, A, Abdel Dayem, K, Mahomed, SH, Diab, MJ. Pharmacy leadership during emergency preparedness: insights from the Middle East and South Asia. Am J Health Syst Pharm. 2020;77(15):1191-1194. doi:10.1093/ajhp/zxaa1333.
Google Scholar | Crossref | Medline8. Dodds, LJ . Optimising pharmacy input to medicines reconciliation at admission to hospital: lessons from a collaborative service evaluation of pharmacy-led medicines reconciliation services in 30 acute hospitals in England. Eur J Hosp Pharm. 2014;21:95-101.
Google Scholar | Crossref9. Graabæk, T, Kjeldsen, LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359-373. doi:10.1111/bcpt.12062.
Google Scholar | Crossref | Medline | ISI10. U.S. Food and Drug Administration . Drug safety communication: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-againstuse-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or (accessed September 25, 2020).
Google Scholar11. Gunterus, A, Lopchuk, S, Dunn, C, Floyd, R, Normandin, B. Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital. Mental Health Clinician. 2016;6(5):242-247.
Google Scholar | Crossref | Medline12. Salameh, LK, Abu Farha, RK, Abu Hammour, KM, Basheti, IA. Impact of pharmacist’s directed medication reconciliation on reducing medication discrepancies during transition of care in hospital setting. J Pharm Health Serv Res. 2019;10:149-156. doi:10.1111/jphs.12261.
Google Scholar | Crossref13. Faqeer, N, Mustafa, N, Abd Al-jalil, N, Qur’an, T. Impact of clinical pharmacists in an inpatient medical oncology service: a prospective study at a comprehensive cancer center in Jordan. J Oncol Pharm Pract. 2020;27(4):897-901. doi:10.1177/1078155220943277
Google Scholar | SAGE Journals